The FDA approved the second respiratory syncytial virus vaccine for adults 60 and older on May 31. 

Berberine, a supplement made from plants, is gaining popularity across social media and online searches as a possible alternative to the expensive, prescription-only drugs like Ozempic and Mounjaro, NBC News reports.

Mark Cuban Cost Plus Drug Co. announced that beginning in July it will sell a branded Humira biosimilar known as Yusimry. It is the first biologic product offered by the company.

Colorado acting Gov. Dianne Primavera signed legislation May 30 that bans using the body mass index when determining care for eating disorder patients and prohibits the sale of diet pills to people under 18. 

Johnson & Johnson-owned Janssen Pharmaceuticals has submitted an application to the FDA for approval of what would be the first tablet therapy for patients with pulmonary arterial hypertension. 

Drug prices are rising faster than inflation, according to a new report from the American Hospital Association.

The FDA proposed a new, one-page medication guide outline for prescription drugs and biologics to ensure a "consistent and easy-to-understand format" for patients, the agency said May 30. 

There's a case for EDs to dispense medications as the U.S. tracks low medication adherence after emergency visits, according to an American Academy of Pediatrics study published May 30. 

Health experts are hoping the next altered COVID-19 vaccine will return to being monovalent but focus solely on XBB.1, The Atlantic reported May 26. 

This live episode from the Becker’s Hospital Review 13th Annual Meeting in Chicago features Desi Kotis, Chief Pharmacy Executive at University of San Francisco Health System. Here, she discusses the opportunities that are coming up now that the federal state…